Marking progress in preventing neonatal group B strep infection

Article

I've been on service this month caring for hospitalized patients and, once again, I'm reminded that managing illness in children isn't as straightforward as it used to be.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Recent Videos
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Related Content
Early antibiotic exposure disrupts infant immune memory, study shows | Image Credit: © Anatta_Tan - stock.adobe.com.

Early antibiotic exposure disrupts infant immune memory, study shows

Morgan Ebert, Managing Editor
July 15th 2025
Article

Early antibiotic exposure disrupts infant immune development by altering gut microbiota, highlighting inosine's potential as a therapeutic target for immune restoration.

What's going on with polio, monkeypox, and COVID-19

What's going on with polio, monkeypox, and COVID-19

Miranda Hester
August 19th 2022
Podcast

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

Specific groups with chronic conditions who could most benefit from RSV prophylaxis | Image Credit: © Peter Hansen - © Peter Hansen - stock.adobe.com.

Specific groups with chronic conditions who could most benefit from RSV prophylaxis

Joshua Fitch, Senior Editor
July 8th 2025
Article

A newly-published study identified specific groups of higher-risk children that could benefit most from monoclonal antibodies.

What Omicron could mean for the pandemic

What Omicron could mean for the pandemic

Miranda Hester
January 7th 2022
Podcast

Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.

Surge in pediatric Mycoplasma pneumoniae hospitalizations reported in 2024: Image Credit: © Pixel-Shot - stock.adobe.com.

Surge in pediatric Mycoplasma pneumoniae hospitalizations reported in 2024

Morgan Ebert, Managing Editor
June 26th 2025
Article

Mycoplasma pneumoniae caused 1 in 2 pediatric pneumonia hospitalizations in 2024, with sharp increases seen across all age groups, according to a recent CDC MMWR report.

ACIP updates: Committee votes 5-2 to recommend clesrovimab to protect against RSV | Image Credit: © JJHVEPhoto - © JHVEPhoto - stock.adobe.com.

ACIP updates: Committee recommends clesrovimab for RSV, reaffirms routine influenza vaccination

Joshua Fitch, Senior Editor
June 26th 2025
Article

The final recommendation sign off decision will go to HHS secretary Robert F. Kennedy Jr.

© 2025 MJH Life Sciences

All rights reserved.